[Smoking-related interstitial lung diseases]. / Raucherassoziierte interstitielle Lungenerkrankungen.
Radiologie (Heidelb)
; 62(9): 738-746, 2022 Sep.
Article
em De
| MEDLINE
| ID: mdl-35736996
ABSTRACT
CLINICAL ISSUE Smoking-related interstitial lung diseases are a heterogeneous group of pulmonary abnormalities. The correct diagnosis has prognostic and therapeutic implications. This article introduces the most common smoking-related interstitial lung diseases and describes a structured approach to support the diagnostic workflow. PRACTICAL RECOMMENDATIONS:
Computed tomography is pivotal in the diagnostic workflow of smoking-related interstitial lung diseases and may reduce the number of unnecessary lung biopsies. To achieve high diagnostic accuracy, a standardized scanning protocol, and a structured assessment approach should be utilized. During inflammatory stages of respiratory bronchiolitis (RB), respiratory bronchiolitis interstitial lung diseases (RB-ILD), and desquamative interstitial pneumonia (DIP), cessation of smoking as well as the use of steroids are the treatment of choice. In case of fibrotic changes (e.g., in idiopathic pulmonary fibrosis [IPF]), antifibrotic therapy with nintedanib and pirfenidone may be used. Patients with suspected smoking-related interstitial lung disease should be discussed in interdisciplinary board meetings.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bronquiolite
/
Doenças Pulmonares Intersticiais
/
Fibrose Pulmonar Idiopática
Idioma:
De
Ano de publicação:
2022
Tipo de documento:
Article